Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
n-acetylcysteine + ascorbic acid is a combination of two antioxidant agents—N-acetylcysteine (NAC), a precursor to glutathione and direct free radical scavenger, and ascorbic acid (vitamin C), an essential nutrient with antioxidant properties. This combination has been studied for its additive or synergistic effects in reducing oxidative stress, mutagenicity, and tissue injury in various clinical settings. Mechanistically, NAC replenishes intracellular glutathione stores and directly neutralizes reactive oxygen species (ROS), while ascorbic acid acts both as an antioxidant and under certain conditions may exhibit pro-oxidant activity. The combination has shown potential benefits in cancer chemoprevention[1], prevention of contrast-induced nephropathy[3][7], sepsis management[2], and other pharmacological interventions where oxidative stress plays a role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n-acetylcysteine + ascorbic acid.